Oscar Health, Inc.
For the period ended Jun 30, 2026. Filed Aug 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a)None.
(b) None.
(c) On June 18, 2026, Vanessa A. Wittman, a member of the Company’s board of directors, entered into a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c). Ms. Wittman’s plan is for the sale of up to 25,000 shares of Class A common stock through April 15, 2027. The plan terminates on the earlier of the date all the shares under the plan are sold and April 15, 2027. No trades will commence under the plan until September 18, 2026, after the expiration of the applicable cooling off period.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.